Which Four Sectors Need Higher Interest Rates?
Negative real interest rates have run their course.
It would be nice if central banks were held to similar standards. But they are not, and therefore they are allowed to hold onto such untested notions as low interest rates stimulate economic activity. What they really do is reward Wall Street and create an illusion of prosperity.
Well, here we are, after four and one-half years of a zero interest rate policy (ZIRP), after two rounds of money-printing, after extensive twisting. These policies have been so successful that the US record-low 10-year Treasury yields look Brobdingnagian in comparison to their German bunds counterparts.
The US has negative real interest rates out to 2027; the UK out to 2062, and even little Denmark has negative nominal yields out to three years; how rotten is that?
Industry Group Impact
If we look at the partial contribution of 10-year Treasury yields to US industry groups, we see the net beta-weighted measure is negative: Lower yields are a positive for the market, all else held equal. However, that is deceptive as it masks a very pronounced sectoral skew. Industry groups with a negative partial contribution from higher yields are concentrated in the defensive sectors of health care, consumer staples, and utilities (XLV, XLP and XLU sector ETFs). Lower yields will help these groups, but these sectors seldom provide strong market leadership.
Click to enlarge
Now take a look at what is on the right-hand side of the table.
These industry groups are concentrated in the basic materials, industrials, financial and energy sectors. Those are groups capable of providing market leadership.
If the Federal Reserve has been trying to create inflation as a way to repudiate the federal debt, it might have boosted the energy and basic materials sectors (sector ETFs XLE and XLB). Or if lower interest rates boosted financials (sector ETF XLF) via the carry mechanism, they would have done so by now.
So, was the ZIRP, twisting, and money printing the medicine after all? Or the placebo?
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter